An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Atopic Dermatitis
Trial Locations (25)

T2J 7E1

Dermatology Research Institute - Blackfoot Trail /ID# 246344, Calgary

T2W 4X9

Laser Rejuvenation Clinics Inc. /ID# 255303, Calgary

T3K 6B8

Rejuvenation Dermatology Clinic Calgary North /ID# 255623, Calgary

T5J 3S9

Rejuvenation Dermatology - Edmonton Downtown /ID# 246298, Edmonton

T5K 2V4

Stratica Medical /ID# 254940, Edmonton

T5N 1L5

Rejuvaderm /ID# 255850, Edmonton

T6X 0N9

Alpha Clinic Research Inc. /ID# 248015, Edmonton

V3R 6A7

Dr. Chih-ho Hong Medical Inc. /ID# 246841, Surrey

B3H 1V7

Nova Scotia Health /ID# 248136, Halifax

N6A 5R9

Fiona Lovegrove Medicine Professional Corporation /ID# 255784, London

L3P 1X2

Lynde Institute for Dermatology /ID# 246341, Markham

L2H 1H5

Allergy Research Canada Inc. /ID# 251916, Niagara Falls

K9J 5K2

SKiN Centre for Dermatology /ID# 246291, Peterborough

L4B 1L1

York Dermatology Clinic and Research Centre /ID# 246921, Richmond Hill

M3B 0A7

Canadian Dermatology Centre /ID# 246334, Toronto

M4C 1L1

FACET Dermatology /ID# 254914, Toronto

M5A 3R6

AvantDerm, Toronto, CA /ID# 250941, Toronto

M5G 1E2

Evidence based medical educator Inc. /ID# 246687, Toronto

J2B 5L4

Dr. Isabelle Delorme Inc. /ID# 246296, Drummondville

H7N 6L2

Clinique D /ID# 247330, Laval

H7P 4K7

Roula Rassi MD Inc /ID# 252563, Laval

G1V 4T3

Diex Recherche Québec Inc. /ID# 247696, Québec

G1W 4R4

Centre de Recherche St-Louis /ID# 252223, Québec

J7Z 7E2

Dre Angelique Gagne-Henley M.D. inc. /ID# 246457, Saint-Jérôme

H4G 3E7

Sima Recherche inc. /ID# 248338, Verdun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY